newsfilter
← Latest News
GlobeNewswire·

Pacira BioSciences Reports First Quarter 2026 Financial Results

-- Total revenue of $177 million, reflecting increase of 5 percent over first quarter 2025 driven by growth across commercial portfolio, including EXPAREL volume growth of 7 percent -- -- Completed enrollment in Phase 3